InspireMD, Inc.
جودة البيانات: 100%
NSPR
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
KWD 1.29
▼
KWD 0.02
(-1.53%)
القيمة السوقية: 61.66 M
السعر
KWD 1.32
القيمة السوقية
61.66 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue grew 18.88% annually over 5 years — strong growth
Negative free cash flow of -36.77 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9.23%
النمو
Revenue Growth (5Y)
18.88%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)28.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-115.67%
أقل من متوسط القطاع (-54.01%)
ROIC-85.27%
Net Margin-543.33%
Op. Margin-552.56%
الأمان
Debt / Equity
N/A
Current Ratio6.51
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-1.26 | -2.13
أعلى من متوسط القطاع (-1.49)
P/B Ratio0.96
EV/EBITDA0.00
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -1.3 | -1.5 |
| P/B | 1.0 | 1.6 |
| ROE % | -115.7 | -54.0 |
| Net Margin % | -543.3 | -41.5 |
| Rev Growth 5Y % | 18.9 | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
3 محللين
Strong Buy
الحالي
KWD 1.29
المستهدف
KWD 5.00
KWD 4.00
KWD 5.00
KWD 6.00
التوقعات
مكرر الربحية المستقبلي
-2.13
ربحية السهم المستقبلية
-KWD 0.61
الإيرادات المقدّرة
27.18 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.61
-KWD 0.65 – -KWD 0.55
|
27.18 M | 3 |
| FY2026 |
-KWD 0.73
-KWD 0.76 – -KWD 0.70
|
13.91 M | 3 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.18
-KWD 0.19 – -KWD 0.18
|
2.95 M | 3 |
| 2026 Q1 |
-KWD 0.18
-KWD 0.19 – -KWD 0.16
|
2.70 M | 3 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.19 | -KWD 0.14 | +27.6% |
| Q32025 | -KWD 0.20 | -KWD 0.17 | +12.8% |
| Q22025 | -KWD 0.26 | -KWD 0.26 | 0.0% |
| Q12025 | -KWD 0.20 | -KWD 0.22 | -10.0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28.11% | Revenue Growth (3Y) | 20.29% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18.88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 8.98 M | Net Income (TTM) | -48.79 M |
| ROE | -115.67% | ROA | -87.26% |
| Gross Margin | 29.50% | Operating Margin | -552.56% |
| Net Margin | -543.33% | Free Cash Flow (TTM) | -36.77 M |
| ROIC | -85.27% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 6.51 |
| Interest Coverage | N/A | Asset Turnover | 0.16 |
| Working Capital | 59.58 M | Tangible Book Value | 64.11 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.26 | Forward P/E | -2.13 |
| P/B Ratio | 0.96 | P/S Ratio | 6.87 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 0.00 | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.27 | Fwd Earnings Yield | N/A |
| FCF Yield | -59.63% | ||
| Market Cap | 61.66 M | Enterprise Value | -1.75 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.76 | Revenue / Share | 0.19 |
| FCF / Share | -0.79 | OCF / Share | -0.75 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 18.51% | FCF Conversion | 75.36% |
| SBC-Adj. FCF | -48.69 M | Growth Momentum | 9.23 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.98 M | 7.01 M | 6.21 M | 5.17 M | 4.50 M |
| Net Income | -48.79 M | -32.01 M | -19.92 M | -18.49 M | -14.92 M |
| EPS (Diluted) | -0.76 | -0.76 | -0.82 | — | — |
| Gross Profit | 2.65 M | 1.51 M | 1.81 M | 1.12 M | 754,000.0 |
| Operating Income | -49.61 M | -33.50 M | -21.14 M | -18.71 M | -14.72 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 15.00 M | 13.63 M | 7.98 M | 7.81 M | 5.16 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 476.00 M | 280.00 M | 232.00 M | 188,000.0 | 161,000.0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 63,000.0 | 59,000.0 | 65,000.0 | 28,000.0 | 45,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 69.40 M | 46.81 M | 47.64 M | 24.65 M | 39.71 M |
| Total Liabilities | 14.20 M | 10.72 M | 8.14 M | 7.26 M | 6.18 M |
| Shareholders' Equity | 55.20 M | 36.09 M | 39.50 M | 17.39 M | 33.53 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 8.94 M | 18.92 M | 9.64 M | 4.63 M | 12.00 M |
| Current Assets | 61.47 M | 40.52 M | 44.16 M | 21.33 M | 37.09 M |
| Current Liabilities | 10.71 M | 7.68 M | 6.02 M | 5.07 M | 4.35 M |
{"event":"ticker_viewed","properties":{"ticker":"NSPR","listing_kind":"stock","pathname":"/stocks/nspr","exchange":"NASDAQ","country":"US"}}